318.77
                                            Schlusskurs vom Vortag:
              $313.01
            Offen:
              $313.61
            24-Stunden-Volumen:
                631.85K
            Relative Volume:
              1.03
            Marktkapitalisierung:
                $22.44B
            Einnahmen:
              $2.36B
            Nettoeinkommen (Verlust:
              $236.10M
            KGV:
              97.01
            EPS:
                3.286
            Netto-Cashflow:
                $382.50M
            1W Leistung:
              -2.16%
            1M Leistung:
              +3.12%
            6M Leistung:
                +24.03%
            1J Leistung:
              +35.30%
            Insulet Corporation Stock (PODD) Company Profile
Firmenname
                  
                      Insulet Corporation
                    
                Sektor
                  Branche
                  Telefon
                  
                      978-600-7000
                    
                Adresse
                  
                      100 NAGOG PARK, ACTON, MA
                    
                Vergleichen Sie PODD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                PODD
                            
                             
                        Insulet Corporation 
                           | 
                    318.77 | 22.03B | 2.36B | 236.10M | 382.50M | 3.286 | 
| 
                         
                          
                                ABT
                            
                             
                        Abbott Laboratories 
                           | 
                    123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 | 
| 
                         
                          
                                BSX
                            
                             
                        Boston Scientific Corp 
                           | 
                    98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 | 
| 
                         
                          
                                SYK
                            
                             
                        Stryker Corp 
                           | 
                    358.16 | 136.23B | 24.38B | 2.94B | 4.07B | 7.6159 | 
| 
                         
                          
                                MDT
                            
                             
                        Medtronic Plc 
                           | 
                    90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 | 
| 
                         
                          
                                EW
                            
                             
                        Edwards Lifesciences Corp 
                           | 
                    83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 | 
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-10-21 | Fortgesetzt | Stifel | Buy | 
| 2025-09-08 | Fortgesetzt | Oppenheimer | Outperform | 
| 2025-06-16 | Eingeleitet | Truist | Buy | 
| 2025-05-30 | Eingeleitet | Goldman | Buy | 
| 2025-05-13 | Hochstufung | Wolfe Research | Peer Perform → Outperform | 
| 2025-04-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform | 
| 2025-03-06 | Eingeleitet | RBC Capital Mkts | Outperform | 
| 2024-11-06 | Eingeleitet | Bernstein | Outperform | 
| 2024-05-30 | Eingeleitet | Redburn Atlantic | Buy | 
| 2024-05-07 | Hochstufung | Wolfe Research | Peer Perform → Outperform | 
| 2023-12-21 | Hochstufung | Robert W. Baird | Neutral → Outperform | 
| 2023-12-04 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight | 
| 2023-10-02 | Hochstufung | Jefferies | Hold → Buy | 
| 2023-08-21 | Hochstufung | Citigroup | Neutral → Buy | 
| 2023-08-21 | Herabstufung | Robert W. Baird | Outperform → Neutral | 
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight | 
| 2023-01-26 | Eingeleitet | Wolfe Research | Peer Perform | 
| 2022-11-04 | Hochstufung | Piper Sandler | Neutral → Overweight | 
| 2022-10-18 | Eingeleitet | Barclays | Equal Weight | 
| 2022-10-12 | Eingeleitet | Jefferies | Hold | 
| 2022-07-11 | Herabstufung | Citigroup | Buy → Neutral | 
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy | 
| 2022-02-03 | Hochstufung | BTIG Research | Neutral → Buy | 
| 2022-02-02 | Hochstufung | UBS | Neutral → Buy | 
| 2022-01-31 | Hochstufung | Oppenheimer | Perform → Outperform | 
| 2021-07-21 | Fortgesetzt | Cowen | Outperform | 
| 2021-05-25 | Eingeleitet | Barclays | Overweight | 
| 2021-04-01 | Hochstufung | SVB Leerink | Mkt Perform → Outperform | 
| 2021-03-19 | Hochstufung | Canaccord Genuity | Hold → Buy | 
| 2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral | 
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral | 
| 2020-07-28 | Eingeleitet | Wells Fargo | Overweight | 
| 2020-04-24 | Herabstufung | SVB Leerink | Outperform → Mkt Perform | 
| 2020-04-03 | Eingeleitet | BofA/Merrill | Neutral | 
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold | 
| 2020-03-05 | Eingeleitet | Citigroup | Buy | 
| 2019-12-10 | Eingeleitet | CFRA | Sell | 
| 2019-10-23 | Eingeleitet | Stifel | Hold | 
| 2019-10-18 | Herabstufung | Canaccord Genuity | Buy → Hold | 
| 2019-10-14 | Herabstufung | BTIG Research | Buy → Neutral | 
| 2019-10-04 | Herabstufung | UBS | Buy → Neutral | 
| 2019-10-03 | Herabstufung | Guggenheim | Buy → Neutral | 
| 2019-08-06 | Hochstufung | JP Morgan | Neutral → Overweight | 
| 2019-06-10 | Herabstufung | Northland Capital | Outperform → Market Perform | 
| 2019-05-06 | Hochstufung | BTIG Research | Neutral → Buy | 
| 2018-04-20 | Eingeleitet | Berenberg | Buy | 
| 2018-02-22 | Bestätigt | Barclays | Overweight | 
| 2018-01-08 | Hochstufung | Raymond James | Mkt Perform → Outperform | 
| 2017-11-03 | Hochstufung | Canaccord Genuity | Hold → Buy | 
| 2017-09-15 | Eingeleitet | Barclays | Overweight | 
                    Alle ansehen
                    
                  
                Insulet Corporation Aktie (PODD) Neueste Nachrichten
What machine learning models say about Insulet CorporationJuly 2025 News Drivers & Reliable Breakout Stock Forecasts - newser.com
Is Insulet Corporation stock poised for growthDollar Strength & Consistent Growth Equity Picks - newser.com
Will Insulet Corporation stock recover after recent dropEarnings Summary Report & Free AI Powered Buy and Sell Recommendations - newser.com
Why Insulet Corporation stock is rated strong buyEarnings Trend Report & Daily Growth Stock Tips - newser.com
Tredje AP fonden Has $2.01 Million Position in Insulet Corporation $PODD - MarketBeat
Why Insulet Corporation stock could outperform in 20252025 AllTime Highs & Intraday High Probability Alerts - newser.com
Chart based exit strategy for Insulet CorporationTrade Entry Summary & Safe Capital Allocation Plans - newser.com
Can Insulet Corporation stock sustain revenue growthQuarterly Market Summary & Stepwise Swing Trade Plans - newser.com
How institutional ownership impacts Insulet Corporation stockJuly 2025 Selloffs & Precise Swing Trade Alerts - newser.com
Simon Quick Advisors LLC Purchases New Position in Insulet Corporation $PODD - MarketBeat
Advanced analytics toolkit walkthrough for Insulet CorporationWeekly Risk Report & Consistent Profit Alerts - newser.com
Why Insulet Corporation (GOV) stock could outperform next yearJuly 2025 Intraday Action & Daily Chart Pattern Signals - newser.com
Sector ETF performance correlation with Insulet CorporationMarket Volume Report & Capital Efficient Trading Techniques - newser.com
Will Insulet Corporation stock deliver strong dividend growth2025 Support & Resistance & Risk Managed Investment Strategies - newser.com
Why Insulet Corporation (GOV) stock stays resilientShort Setup & Long Hold Capital Preservation Plans - newser.com
Will Insulet Corporation outperform the marketQuarterly Performance Summary & Reliable Price Breakout Signals - newser.com
Why Insulet Corporation stock appeals to dividend seekersRate Cut & Weekly High Potential Stock Alerts - newser.com
What technical signals suggest for Insulet Corporation stockJuly 2025 Outlook & Stepwise Entry/Exit Trade Alerts - newser.com
Why Insulet Corporation (GOV) stock could break out in 2025July 2025 Breakouts & Verified High Yield Trade Plans - newser.com
Amalgamated Bank Purchases 890 Shares of Insulet Corporation $PODD - MarketBeat
Is Insulet Corporation stock a buy before product launchesMarket Risk Report & AI Powered Market Trend Analysis - newser.com
Bessemer Group Inc. Sells 4,287 Shares of Insulet Corporation $PODD - MarketBeat
Envestnet Asset Management Inc. Has $41.99 Million Stock Holdings in Insulet Corporation $PODD - MarketBeat
Will Insulet Corporation rebound enough to break evenWeekly Trade Summary & Community Consensus Trade Signals - newser.com
Insulet Corporation $PODD Shares Sold by Jennison Associates LLC - MarketBeat
New York Life Investment Management LLC Sells 7,290 Shares of Insulet Corporation $PODD - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Purchases 1,300 Shares of Insulet Corporation $PODD - MarketBeat
Here's Why Insulet (PODD) is a Strong Growth Stock - sharewise.com
Multi asset correlation models including Insulet Corporation2025 Historical Comparison & Weekly Watchlist for Hot Stocks - newser.com
How to interpret RSI for Insulet Corporation stockWeekly Trade Summary & Community Consensus Trade Signals - newser.com
Insulet Corporation (PODD) Stock Forecasts - Yahoo! Finance Canada
Insulet Corporation (PODD) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Insulet (PODD) to Release Earnings on Thursday - MarketBeat
Full technical analysis of Insulet Corporation stock2025 Bull vs Bear & Growth Focused Entry Point Reports - newser.com
Peering Into Insulet Corp's Recent Short Interest - Sahm
Finanzdaten der Insulet Corporation-Aktie (PODD)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):